title: Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study.
abstract: Auditory hallucinations and delusions are core symptoms of schizophrenia, which interact with each other. The attribution of auditory hallucinations to other people is considered to lead to secondary delusions. This study examined whether brief psychoeducation can change the cognition of auditory hallucinations, particularly, their attribution, and thus alleviate secondary delusions. Twenty-two schizophrenic patients with auditory hallucinations were recruited in this open study. The intervention consisted of five sessions during the course of 4 weeks. Outcome measures were used to assess delusions, beliefs about auditory hallucinations, and depression. At the end of the intervention, statistically significant reduction was observed in both delusions and depression. Beliefs about hallucinations showed statistically significant improvement in terms of malevolence, omnipotence, and resistance but not in terms of benevolence and engagement. In conclusion, the present study suggests that psychoeducation might be useful in reducing secondary delusions without exacerbating a depressive state.
authors.affiliation: *Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; †Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan; ‡Shiseikai Yagoto Hospital, Nagoya, Japan; and §Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.Dr Watanabe is now at the Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology & Psychiatry, Kodaira, Tokyo, Japan.
authors.forename: Nao
authors.initials: N
authors.lastname: Shiraishi
authors.forename: Norio
authors.initials: N
authors.lastname: Watanabe
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kinoshita
authors.forename: Atsuko
authors.initials: A
authors.lastname: Kaneko
authors.forename: Shinichi
authors.initials: S
authors.lastname: Yoshida
authors.forename: Toshiaki A
authors.initials: TA
authors.lastname: Furukawa
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Akechi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003702:Delusions / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D003863:Depression / Q000175:diagnosis* / Q000517:prevention & control; D004334:Drug Administration Schedule; D005260:Female; D006212:Hallucinations / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011569:Psychiatric Status Rating Scales; D011615:Psychotherapy, Group / Q000379:methods; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D012565:Schizophrenic Psychology; D057566:Self Report; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents